Clinical Discovery Program
The purpose of the Clinical Discovery Program is to rapidly translate and test novel diagnostic and therapeutic approaches from bench to bedside. This Program focuses primarily on technologies previously developed at CSB but also applies other new technologies as they are related to human biology. The primary fields of interest are currently in cancer dx, clinical imaging and systems analyses. Investigators in this program are practicing clinician scientists from Massachusetts General Hospital and collaborators from other Harvard Medical School teaching hospitals. The program is primarily funded through grants from NIH.
High-Content Biopsies Facilitate Molecular Analyses and Do Not Increase Complication Rates in Patients With Advanced Solid Tumors
JCO Precis Oncol. 2017;1:1-9
Effect of androgen deprivation and radiation therapy on MRI fiber tractography in prostate cancer: Can we assess treatment response on imaging?
2013-12-30: Mukesh G. Harisinghani, MD, has been promoted to Professor of Radiology, Harvard Medical School. Congratulations Mukesh!
2012-11-28: Sandeep Hedgire, MD receives the Cum Laude award for his education exhibit at the 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America.
New Boston Museum of Science's Virtual Exhibit
features work of Drs. Weissleder and Harisinghani
on the design of a clinical trial to determine how iron-oxide nanoparticles could enhance a diagnostic image produced by an MRI machine to the extent that the spread of cancer could be accurately assessed.